Arthroscopy is the minimally invasive surgical procedure, used to diagnose and treat joint problems concerning shoulders, knee, hips, elbow, and others with the help of imaging equipment named arthroscope. The technique provides better diagnostic results compared to X-ray and other diagnostic technologies. Unlike traditional open surgical procedures, arthroscopy is minimally invasive procedures and require combatively less healing time. Moreover, arthroscopy can be performed on all age groups and professional athletes. According to the American Orthopaedic Society for Sports Medicine, around 4 million people are undergoing knee arthroscopies whereas the number of shoulder arthroscopies is 1.4 million per annum. Moreover, the growing participation of people in sports and outdoor activities present new avenues for world arthroscopy market. Similarly, increasing awareness amongst patients and growing demand for minimally invasive surgeries have contributed towards the surge in the world market.
The key factors that are responsible for the market growth includes rise in number of obese population, increasing geriatric population prose to the knee and hip injuries, and increasing incidences of musculoskeletal disorders, namely bone tumor, rheumatoid arthritis, and osteoarthritis among others. However, stringent taxation policies, lack of favorable reimbursement and unavailability of skilled surgeons are some of the factors limiting the market growth. The advancement in technology would create huge opportunities for growth of the market.
The world Arthroscopy devices market is segmented based on product type, end users, application and geography. Furthermore, the product market is classified into arthroscopes, arthroscopic H & instruments, radiofrequency probe, drill guide, fluid management devices, soft tissue repair devices and power saver systems. The market is segmented based on end users into hospitals, orthopedic clinics, and other end users. Based on application, the market is segmented into knee injuries, shoulder injuries, back and spine injuries, ankle and foot injuries, hip and groin injuries, elbow and wrist injuries and other injuries. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
The leading manufacturers profiled in the report are Arthrex, Inc., Conmed Corporation, Arthrocare Corporation, Biomet Inc., Depuy Synthes Companies, Tornier N.V., Smith & Nephew PLC, and Stryker Corporation, Bioventu, OrthoSpace, Cayenne Medical, NuOrtho Surgical, Inc.
Some of the key strategies employed by Arthroscopy manufacturers include joint ventures, mergers & acquisition, agreements and partnerships, among others. For instance, In Jan 2016, Bioventus has launched of Duralone, single injection joint-fluid osteoarthritis treatment in Taiwan to enter into patient care market. Similarly, on March 2015, Cayenne Medical have launched two new products namely Quattro Bolt Tenodesis Screw and the Short SureLock System, which helps surgeons to easily navigate into intricate joints.
KEY BENEFITS FOR STAKEHOLDERS
The report offers a detailed analysis of key driving and restraining factors of the world Arthroscopy devices market.
This report offers an extensive quantitative analysis of the current market size and forecast through 2015-2020, which assists in identifying the prevailing market opportunities.
Competitive intelligence and SWOT analysis of leading manufacturers of World Arthroscopy devices market highlights the business practices followed by leading market players across various geographies.
An in-depth analysis of dominant market shares for each segment helps in understanding the current market trend.
Geographically, the world arthroscopy devices market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.The report offers an exhaustive information about recent developments, untapped geographic markets, and new product launches.
Arthroscopy Devices Market Key Segments
Arthroscopic H and Instruments
Fluid Management Devices
Power Saver Systems
Soft Tissue Repair Device
Back and spine injuries
Ankle and Foot injuries
Hip and groin injuries
Elbow and wrist injuries
By End Users
Other end users
SIMILAR MARKET STUDIES
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, ...
May 2017 | $5370 | View Details >>
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimerâ€™s disease, Parkinson disease, and other neurological disorders.
May 2017 | $5370 | View Details >>
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-BarrÃ© Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022
Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.
May 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research